Functional Urologic Surgery in Neurogenic and Oncologic Diseases 2016
DOI: 10.1007/978-3-319-29191-8_13
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum Toxin Bladder Injection in the Treatment of Neurogenic Detrusor Overactivity and Idiopathic OAB

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…19 However, Marzi et al showed that side effects occurred in patients that received both low and high doses. 20 In our cases, the patients received 300 U onabotulinumtoxin A at each treatment, which is a relatively low dose compared to dosages often used in skeletal muscle. 1 The question of why the presentation in these two cases was focal and not systemic remains puzzling especially in case one where baseline motor strength was greater.…”
Section: Discussionmentioning
confidence: 94%
“…19 However, Marzi et al showed that side effects occurred in patients that received both low and high doses. 20 In our cases, the patients received 300 U onabotulinumtoxin A at each treatment, which is a relatively low dose compared to dosages often used in skeletal muscle. 1 The question of why the presentation in these two cases was focal and not systemic remains puzzling especially in case one where baseline motor strength was greater.…”
Section: Discussionmentioning
confidence: 94%